Bernhardt L. Trout is the Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering at MIT. He received his S.B. and S.M. degrees from MIT and his Ph.D. from the University of California at Berkeley. He performed post-doctoral research at the Max-Planck Institute.
Trout’s research focuses on the development of advanced manufacturing processes and rational tools for formulation and product design. In 2007, with several colleagues, he set up the Novartis-MIT Center for Continuous Manufacturing, a $85 million partnership with the objective of transforming pharmaceutical manufacturing. This led in 2011 to the first end-to-end fully integrated and automated pharmaceutical process. He was also Co-Chair of the Singapore-MIT Alliance Program on Chemical and Pharmaceutical Engineering. In addition to Novartis, he has worked with many other pharmaceutical companies in research or consulting. He has also developed a host of computational methods for the design of drug products taking into account developability and manufacturability and continues to work in the field of continuous manufacturing. He runs a project currently with the FDA on a continuous lyophilization process. In addition, he is Co-Chair of the International Symposium on Continuous Manufacturing of Pharmaceuticals. He has published over 200 papers and has 18 patents issued.